1Angheiescu I, Szegedi A,Schlegel S,et al. Combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trial. Eur Neuropsychopharmacol, 1998,8 (4) : 315 - 320. 被引量：1
2Wetzel H, Anghelescu I, Szegedi A, et al. Pharmacokinetic interaction of clozapinc with selective seretonin reuptake inhibition:differentiaL effects of fluvoxamine and paroxetine in a prospective study. J Clin Psychopharmacol, t998,18(1) :2-9. 被引量：1
3Joos AA, Koning F, Frank UG, et al. Dose dependent pharmacokinetic interartion of clozapine and paroxetine in nn extensive metabolizer. Pharmacopsychiatry, 1997. 30(6) : 266 - 270. 被引量：1
4Centoninino F, Baldessarini RJ, Frankenberg FR. et al. Serum levels of clozapine and norelozapine in patients treated with selective serotonin reuptake inhihitors. Am J Psychiatry, 1996,153(6):820-822. 被引量：1
5George TP, Innamorato L, Semyak MJ, et al. Leukopenia associated with addition of paroxetine to clopine. J Clin Psychiatry, 1998, 59(1): 3. 被引量：1
